CRISPR QC
PrivateLast Round
Series A
Jan 5, 2024
Total Funding Raised
$11.6M
Company Overview
CRISPR QC is a biotechnology company that provides an analytics platform to simulate and analyze the gene editing process.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Sensors
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CRISPR QC Comparables
Compare CRISPR QC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| COBO Technologies | 87% | |
| Countagen AB | 81% | |
| Paragraf | 78% | |
CRISPR QC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 5, 2024 | ||||
| Seed | Jan 9, 2023 | ||||
| Accelerator | Aug 12, 2022 |
CRISPR QC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Serra Ventures | Seed |
| EvoNexus | Accelerator |
| Xcellerant Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 5, 2024
$10M round led by Xcellerant Ventures.
- Jan 9, 2023
$1.6M round led by Serra Ventures
CRISPR QC Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CRISPR QC's valuation, stock price, and market status.